Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| QuidelOrtho CorpQDEL · Entity 4986 | SVP, Research & Development | July 28, 2024 | July 30, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
QuidelOrtho Corp
Report date July 28, 2024 · Filed July 30, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 36,357 |
Ending reported balance
After 2024-07-28 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2024-07-28 · Grant · Acquired 1,170 · Balance 36,951 F1: Reflects release of restricted stock units that were previously reported on a Form 4. Row 2 · 2024-07-28 · Tax withholding · Disposed 594 · Balance 36,357 F2: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2024-07-28 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2024-07-28 · Exercise / conversion · Disposed 1,170 · Balance 0 F3: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F4: 1,170 shares vested on July 28, 2022; 1,170 shares vested on July 28, 2023; and 1,170 shares vested on July 28, 2024. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects release of restricted stock units that were previously reported on a Form 4.
F2: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units.
F3: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock.
F4: 1,170 shares vested on July 28, 2022; 1,170 shares vested on July 28, 2023; and 1,170 shares vested on July 28, 2024.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
QUIDEL CORP /DE/
Report date May 27, 2022 · Filed June 01, 2022
Section 16 reporting ended · disclosed 2022-06-01. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Ending reported balance
After 2022-05-27 transaction · row 3
3 source rows · reconciled sequenceRow 1 · 2022-05-27 · Grant · Acquired 4,376 · Balance 20,932 F1: Reflects release of restricted stock units that were previously reported on a Form 4. Row 2 · 2022-05-27 · Tax withholding · Disposed 2,170 · Balance 18,762 F2: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Row 3 · 2022-05-27 · Disposition to issuer · Disposed 18,762 · Balance 0 F3: Pursuant to the Business Combination Agreement, dated as of December 22, 2021 (the "Business Combination Agreement") by and among Quidel Corporation ("Quidel"), Ortho Clinical Diagnostics Holdings plc, QuidelOrtho Corporation ("QuidelOrtho"), Orca Holdco, Inc., Laguna Merger Sub, Inc. and Orca Holdco 2, Inc., each share of common stock of Quidel beneficially owned by the Reporting Person at the effective time of the transaction contemplated by the Business Combination Agreement will be exchanged for one share of common stock of QuidelOrtho. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2022-05-27 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2022-05-27 · Exercise / conversion · Disposed 4,376 · Balance 0 F4: Each restricted stock unit represents the right to receive one share of Quidel common stock. F5: Vested in full. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2022-05-27 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2022-05-27 · Disposition to issuer · Disposed 3,925 · Balance 0 F4: Each restricted stock unit represents the right to receive one share of Quidel common stock. F8: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F9: 3,925 shares will vest on February 4, 2023. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2022-05-27 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2022-05-27 · Disposition to issuer · Disposed 2,743 · Balance 0 F4: Each restricted stock unit represents the right to receive one share of Quidel common stock. F8: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F10: Release of restricted stock units was deferred pursuant to Quidel's deferred compensation program applicable to participating employees and will occur according to the elected deferral schedule. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2022-05-27 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2022-05-27 · Disposition to issuer · Disposed 823 · Balance 0 F4: Each restricted stock unit represents the right to receive one share of Quidel common stock. F8: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F10: Release of restricted stock units was deferred pursuant to Quidel's deferred compensation program applicable to participating employees and will occur according to the elected deferral schedule. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2022-05-27 transaction · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · 2022-05-27 · Disposition to issuer · Disposed 4,268 · Balance 0 F4: Each restricted stock unit represents the right to receive one share of Quidel common stock. F8: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F11: 4,268 shares will vest on February 4, 2023. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2022-05-27 transaction · row 11
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 11 · 2022-05-27 · Disposition to issuer · Disposed 1,962 · Balance 0 F4: Each restricted stock unit represents the right to receive one share of Quidel common stock. F8: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F12: 1,962 shares will vest in equal installments on July 1, 2022 and July 1, 2023. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2022-05-27 transaction · row 12
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 12 · 2022-05-27 · Disposition to issuer · Disposed 2,625 · Balance 0 F4: Each restricted stock unit represents the right to receive one share of Quidel common stock. F8: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F13: 1,312 shares will vest on February 1, 2023; and 1,313 shares will vest on February 1, 2024. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2022-05-27 transaction · row 13
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 13 · 2022-05-27 · Disposition to issuer · Disposed 3,510 · Balance 0 F4: Each restricted stock unit represents the right to receive one share of Quidel common stock. F8: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F14: 3,510 shares will vest in equal installments on July 28, 2022, July 28, 2023 and July 28, 2024. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2022-05-27 transaction · row 14
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 14 · 2022-05-27 · Disposition to issuer · Disposed 10,642 · Balance 0 F4: Each restricted stock unit represents the right to receive one share of Quidel common stock. F8: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F15: 3,547 shares will vest on each of January 31, 2023 and January 31, 2024; 3,548 shares will vest on January 31, 2025. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2022-05-27 transaction · row 15
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 15 · 2022-05-27 · Disposition to issuer · Disposed 7,256 · Balance 0 F4: Each restricted stock unit represents the right to receive one share of Quidel common stock. F8: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F16: 3,628 shares will vest on January 31, 2024; the remaining 3,628 shares will vest in equal installments on January 31, 2025 and January 31, 2026. |
| Non-Qualified Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $46.41 · Expires 2028-01-16 | Direct | 0 |
Reported balance
After 2022-05-27 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2022-05-27 · Disposition to issuer · Disposed 2,303 · Balance 0 F6: Pursuant to the Business Combination Agreement, the Quidel Non-Qualified Stock Options will be converted into an equal number of Non-Qualified Stock Options to purchase shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F5: Vested in full. |
| Non-Qualified Stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $59.12 · Expires 2029-02-04 | Direct | 0 |
Reported balance
After 2022-05-27 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2022-05-27 · Disposition to issuer · Disposed 3,924 · Balance 0 F6: Pursuant to the Business Combination Agreement, the Quidel Non-Qualified Stock Options will be converted into an equal number of Non-Qualified Stock Options to purchase shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F7: 5,888 shares are vested in full; 1,962 shares will vest on February 4, 2023. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects release of restricted stock units that were previously reported on a Form 4.
F2: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units.
F3: Pursuant to the Business Combination Agreement, dated as of December 22, 2021 (the "Business Combination Agreement") by and among Quidel Corporation ("Quidel"), Ortho Clinical Diagnostics Holdings plc, QuidelOrtho Corporation ("QuidelOrtho"), Orca Holdco, Inc., Laguna Merger Sub, Inc. and Orca Holdco 2, Inc., each share of common stock of Quidel beneficially owned by the Reporting Person at the effective time of the transaction contemplated by the Business Combination Agreement will be exchanged for one share of common stock of QuidelOrtho.
F4: Each restricted stock unit represents the right to receive one share of Quidel common stock.
F5: Vested in full.
F6: Pursuant to the Business Combination Agreement, the Quidel Non-Qualified Stock Options will be converted into an equal number of Non-Qualified Stock Options to purchase shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).
F7: 5,888 shares are vested in full; 1,962 shares will vest on February 4, 2023.
F8: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions).
F9: 3,925 shares will vest on February 4, 2023.
F10: Release of restricted stock units was deferred pursuant to Quidel's deferred compensation program applicable to participating employees and will occur according to the elected deferral schedule.
F11: 4,268 shares will vest on February 4, 2023.
F12: 1,962 shares will vest in equal installments on July 1, 2022 and July 1, 2023.
F13: 1,312 shares will vest on February 1, 2023; and 1,313 shares will vest on February 1, 2024.
F14: 3,510 shares will vest in equal installments on July 28, 2022, July 28, 2023 and July 28, 2024.
F15: 3,547 shares will vest on each of January 31, 2023 and January 31, 2024; 3,548 shares will vest on January 31, 2025.
F16: 3,628 shares will vest on January 31, 2024; the remaining 3,628 shares will vest in equal installments on January 31, 2025 and January 31, 2026.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 27, 2022 Filed Jun 1, 2022 16:23 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | Disposition to issuerRestricted Stock Units · Derivative | 2,625 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-020398 · doc4.xml · derivative · entry 12 Kroll Werner · CIK 0001609320 · SVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,625 shares Expires not disclosed F4 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Quidel common stock. F8 · kind: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F13 · derivative.exercise_date: 1,312 shares will vest on February 1, 2023; and 1,313 shares will vest on February 1, 2024. F13 · derivative.expiration_date: 1,312 shares will vest on February 1, 2023; and 1,313 shares will vest on February 1, 2024. Read SEC document |
| May 27, 2022 Filed Jun 1, 2022 16:23 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | Disposition to issuerRestricted Stock Units · Derivative | 1,962 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-020398 · doc4.xml · derivative · entry 11 Kroll Werner · CIK 0001609320 · SVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,962 shares Expires not disclosed F4 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Quidel common stock. F8 · kind: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F12 · derivative.exercise_date: 1,962 shares will vest in equal installments on July 1, 2022 and July 1, 2023. F12 · derivative.expiration_date: 1,962 shares will vest in equal installments on July 1, 2022 and July 1, 2023. Read SEC document |
| May 27, 2022 Filed Jun 1, 2022 16:23 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | Disposition to issuerRestricted Stock Units · Derivative | 4,268 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-020398 · doc4.xml · derivative · entry 10 Kroll Werner · CIK 0001609320 · SVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,268 shares Expires not disclosed F4 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Quidel common stock. F8 · kind: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F11 · derivative.exercise_date: 4,268 shares will vest on February 4, 2023. F11 · derivative.expiration_date: 4,268 shares will vest on February 4, 2023. Read SEC document |
| May 27, 2022 Filed Jun 1, 2022 16:23 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | Disposition to issuerRestricted Stock Units · Derivative | 823 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-020398 · doc4.xml · derivative · entry 9 Kroll Werner · CIK 0001609320 · SVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 823 shares Expires not disclosed F4 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Quidel common stock. F8 · kind: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F10 · derivative.exercise_date: Release of restricted stock units was deferred pursuant to Quidel's deferred compensation program applicable to participating employees and will occur according to the elected deferral schedule. F10 · derivative.expiration_date: Release of restricted stock units was deferred pursuant to Quidel's deferred compensation program applicable to participating employees and will occur according to the elected deferral schedule. Read SEC document |
| May 27, 2022 Filed Jun 1, 2022 16:23 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | Disposition to issuerRestricted Stock Units · Derivative | 2,743 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-020398 · doc4.xml · derivative · entry 8 Kroll Werner · CIK 0001609320 · SVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,743 shares Expires not disclosed F4 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Quidel common stock. F8 · kind: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F10 · derivative.exercise_date: Release of restricted stock units was deferred pursuant to Quidel's deferred compensation program applicable to participating employees and will occur according to the elected deferral schedule. F10 · derivative.expiration_date: Release of restricted stock units was deferred pursuant to Quidel's deferred compensation program applicable to participating employees and will occur according to the elected deferral schedule. Read SEC document |
| May 27, 2022 Filed Jun 1, 2022 16:23 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | Disposition to issuerRestricted Stock Units · Derivative | 3,925 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-020398 · doc4.xml · derivative · entry 7 Kroll Werner · CIK 0001609320 · SVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,925 shares Expires not disclosed F4 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Quidel common stock. F8 · kind: Pursuant to the Business Combination Agreement, the Quidel restricted stock units will be converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F9 · derivative.exercise_date: 3,925 shares will vest on February 4, 2023. F9 · derivative.expiration_date: 3,925 shares will vest on February 4, 2023. Read SEC document |
| May 27, 2022 Filed Jun 1, 2022 16:23 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | Disposition to issuerNon-Qualified Stock Options · Derivative | 3,924 | $0.00 Strike: $59.12 | $0.00 |
DisclosureSEC source: 0000899243-22-020398 · doc4.xml · derivative · entry 6 Kroll Werner · CIK 0001609320 · SVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,924 shares Expires 2029-02-04 F6 · kind: Pursuant to the Business Combination Agreement, the Quidel Non-Qualified Stock Options will be converted into an equal number of Non-Qualified Stock Options to purchase shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F7 · derivative.exercise_date: 5,888 shares are vested in full; 1,962 shares will vest on February 4, 2023. Read SEC document |
| May 27, 2022 Filed Jun 1, 2022 16:23 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | Disposition to issuerNon-Qualified Stock Options · Derivative | 2,303 | $0.00 Strike: $46.41 | $0.00 |
DisclosureSEC source: 0000899243-22-020398 · doc4.xml · derivative · entry 5 Kroll Werner · CIK 0001609320 · SVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,303 shares Expires 2028-01-16 F6 · kind: Pursuant to the Business Combination Agreement, the Quidel Non-Qualified Stock Options will be converted into an equal number of Non-Qualified Stock Options to purchase shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F5 · derivative.exercise_date: Vested in full. Read SEC document |
| May 27, 2022 Filed Jun 1, 2022 16:23 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | Exercise / conversionRestricted Stock Units · Derivative | 4,376 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-020398 · doc4.xml · derivative · entry 4 Kroll Werner · CIK 0001609320 · SVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,376 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of Quidel common stock. F5 · derivative.exercise_date: Vested in full. F5 · derivative.expiration_date: Vested in full. Read SEC document |
| May 27, 2022 Filed Jun 1, 2022 16:23 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | Disposition to issuerCommon Stock | 18,762 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-22-020398 · doc4.xml · nonDerivative · entry 3 Kroll Werner · CIK 0001609320 · SVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F3 · kind: Pursuant to the Business Combination Agreement, dated as of December 22, 2021 (the "Business Combination Agreement") by and among Quidel Corporation ("Quidel"), Ortho Clinical Diagnostics Holdings plc, QuidelOrtho Corporation ("QuidelOrtho"), Orca Holdco, Inc., Laguna Merger Sub, Inc. and Orca Holdco 2, Inc., each share of common stock of Quidel beneficially owned by the Reporting Person at the effective time of the transaction contemplated by the Business Combination Agreement will be exchanged for one share of common stock of QuidelOrtho. F3 · price: Pursuant to the Business Combination Agreement, dated as of December 22, 2021 (the "Business Combination Agreement") by and among Quidel Corporation ("Quidel"), Ortho Clinical Diagnostics Holdings plc, QuidelOrtho Corporation ("QuidelOrtho"), Orca Holdco, Inc., Laguna Merger Sub, Inc. and Orca Holdco 2, Inc., each share of common stock of Quidel beneficially owned by the Reporting Person at the effective time of the transaction contemplated by the Business Combination Agreement will be exchanged for one share of common stock of QuidelOrtho. Read SEC document |
| May 27, 2022 Filed Jun 1, 2022 16:23 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | Tax withholdingCommon Stock | 2,170 | $103.45 | $224,486.50 |
DisclosureSEC source: 0000899243-22-020398 · doc4.xml · nonDerivative · entry 2 Kroll Werner · CIK 0001609320 · SVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,762 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| May 27, 2022 Filed Jun 1, 2022 16:23 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | GrantCommon Stock | 4,376 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-020398 · doc4.xml · nonDerivative · entry 1 Kroll Werner · CIK 0001609320 · SVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,932 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| May 27, 2022 Filed Jun 1, 2022 17:45 UTC | QuidelOrtho Corp QDEL · Entity 4986 | GrantRestricted Stock Units · Derivative | 7,256 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-020510 · doc4.xml · derivative · entry 12 Kroll Werner · CIK 0001609320 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,256 Underlying: Common Stock · 7,256 shares Expires not disclosed F5 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock. F6 · kind: Pursuant to the Business Combination Agreement, the Quidel restricted stock units were converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F14 · derivative.exercise_date: 3,628 shares will vest on January 31, 2024; the remaining 3,628 shares will vest in equal installments on January 31, 2025 and January 31, 2026. F14 · derivative.expiration_date: 3,628 shares will vest on January 31, 2024; the remaining 3,628 shares will vest in equal installments on January 31, 2025 and January 31, 2026. Read SEC document |
| May 27, 2022 Filed Jun 1, 2022 17:45 UTC | QuidelOrtho Corp QDEL · Entity 4986 | GrantRestricted Stock Units · Derivative | 10,642 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-020510 · doc4.xml · derivative · entry 11 Kroll Werner · CIK 0001609320 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,642 Underlying: Common Stock · 10,642 shares Expires not disclosed F5 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock. F6 · kind: Pursuant to the Business Combination Agreement, the Quidel restricted stock units were converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F13 · derivative.exercise_date: 3,547 shares will vest on each of January 31, 2023 and January 31, 2024; 3,548 shares will vest on January 31, 2025. F13 · derivative.expiration_date: 3,547 shares will vest on each of January 31, 2023 and January 31, 2024; 3,548 shares will vest on January 31, 2025. Read SEC document |
| May 27, 2022 Filed Jun 1, 2022 17:45 UTC | QuidelOrtho Corp QDEL · Entity 4986 | GrantRestricted Stock Units · Derivative | 3,510 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-020510 · doc4.xml · derivative · entry 10 Kroll Werner · CIK 0001609320 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,510 Underlying: Common Stock · 3,510 shares Expires not disclosed F5 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock. F6 · kind: Pursuant to the Business Combination Agreement, the Quidel restricted stock units were converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F12 · derivative.exercise_date: 3,510 shares will vest in equal installments on July 28, 2022, July 28, 2023 and July 28, 2024. F12 · derivative.expiration_date: 3,510 shares will vest in equal installments on July 28, 2022, July 28, 2023 and July 28, 2024. Read SEC document |
| May 27, 2022 Filed Jun 1, 2022 17:45 UTC | QuidelOrtho Corp QDEL · Entity 4986 | GrantRestricted Stock Units · Derivative | 2,625 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-020510 · doc4.xml · derivative · entry 9 Kroll Werner · CIK 0001609320 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,625 Underlying: Common Stock · 2,625 shares Expires not disclosed F5 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock. F6 · kind: Pursuant to the Business Combination Agreement, the Quidel restricted stock units were converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F11 · derivative.exercise_date: 1,312 shares will vest on February 1, 2023; and 1,313 shares will vest on February 1, 2024. F11 · derivative.expiration_date: 1,312 shares will vest on February 1, 2023; and 1,313 shares will vest on February 1, 2024. Read SEC document |
| May 27, 2022 Filed Jun 1, 2022 17:45 UTC | QuidelOrtho Corp QDEL · Entity 4986 | GrantRestricted Stock Units · Derivative | 1,962 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-020510 · doc4.xml · derivative · entry 8 Kroll Werner · CIK 0001609320 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,962 Underlying: Common Stock · 1,962 shares Expires not disclosed F5 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock. F6 · kind: Pursuant to the Business Combination Agreement, the Quidel restricted stock units were converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F10 · derivative.exercise_date: 1,962 shares will vest in equal installments on July 1, 2022 and July 1, 2023. F10 · derivative.expiration_date: 1,962 shares will vest in equal installments on July 1, 2022 and July 1, 2023. Read SEC document |
| May 27, 2022 Filed Jun 1, 2022 17:45 UTC | QuidelOrtho Corp QDEL · Entity 4986 | GrantRestricted Stock Units · Derivative | 4,268 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-020510 · doc4.xml · derivative · entry 7 Kroll Werner · CIK 0001609320 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,268 Underlying: Common Stock · 4,268 shares Expires not disclosed F5 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock. F6 · kind: Pursuant to the Business Combination Agreement, the Quidel restricted stock units were converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F9 · derivative.exercise_date: 4,268 shares will vest on February 4, 2023. F9 · derivative.expiration_date: 4,268 shares will vest on February 4, 2023. Read SEC document |
| May 27, 2022 Filed Jun 1, 2022 17:45 UTC | QuidelOrtho Corp QDEL · Entity 4986 | GrantRestricted Stock Units · Derivative | 823 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-020510 · doc4.xml · derivative · entry 6 Kroll Werner · CIK 0001609320 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 823 Underlying: Common Stock · 823 shares Expires not disclosed F5 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock. F6 · kind: Pursuant to the Business Combination Agreement, the Quidel restricted stock units were converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F8 · derivative.exercise_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating employees and will occur according to the elected deferral schedule. F8 · derivative.expiration_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating employees and will occur according to the elected deferral schedule. Read SEC document |
| May 27, 2022 Filed Jun 1, 2022 17:45 UTC | QuidelOrtho Corp QDEL · Entity 4986 | GrantRestricted Stock Units · Derivative | 2,743 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-020510 · doc4.xml · derivative · entry 5 Kroll Werner · CIK 0001609320 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,743 Underlying: Common Stock · 2,743 shares Expires not disclosed F5 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock. F6 · kind: Pursuant to the Business Combination Agreement, the Quidel restricted stock units were converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F8 · derivative.exercise_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating employees and will occur according to the elected deferral schedule. F8 · derivative.expiration_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating employees and will occur according to the elected deferral schedule. Read SEC document |
| May 27, 2022 Filed Jun 1, 2022 17:45 UTC | QuidelOrtho Corp QDEL · Entity 4986 | GrantRestricted Stock Units · Derivative | 3,925 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-020510 · doc4.xml · derivative · entry 4 Kroll Werner · CIK 0001609320 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,925 Underlying: Common Stock · 3,925 shares Expires not disclosed F5 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock. F6 · kind: Pursuant to the Business Combination Agreement, the Quidel restricted stock units were converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F7 · derivative.exercise_date: 3,925 shares will vest on February 4, 2023. F7 · derivative.expiration_date: 3,925 shares will vest on February 4, 2023. Read SEC document |
| May 27, 2022 Filed Jun 1, 2022 17:45 UTC | QuidelOrtho Corp QDEL · Entity 4986 | GrantNon-Qualified Stock Options · Derivative | 3,924 | $0.00 Strike: $59.12 | $0.00 |
DisclosureSEC source: 0000899243-22-020510 · doc4.xml · derivative · entry 3 Kroll Werner · CIK 0001609320 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,924 Underlying: Common Stock · 3,924 shares Expires 2029-02-04 F2 · kind: Pursuant to the Business Combination Agreement, the Quidel Non-Qualified Stock Options were converted into an equal number of Non-Qualified Stock Options to purchase shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F4 · derivative.exercise_date: 5,888 shares are vested in full; 1,962 shares will vest on February 4, 2023. Read SEC document |
| May 27, 2022 Filed Jun 1, 2022 17:45 UTC | QuidelOrtho Corp QDEL · Entity 4986 | GrantNon-Qualified Stock Options · Derivative | 2,303 | $0.00 Strike: $46.41 | $0.00 |
DisclosureSEC source: 0000899243-22-020510 · doc4.xml · derivative · entry 2 Kroll Werner · CIK 0001609320 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,303 Underlying: Common Stock · 2,303 shares Expires 2028-01-16 F2 · kind: Pursuant to the Business Combination Agreement, the Quidel Non-Qualified Stock Options were converted into an equal number of Non-Qualified Stock Options to purchase shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). F3 · derivative.exercise_date: Vested in full. Read SEC document |
| May 27, 2022 Filed Jun 1, 2022 17:45 UTC | QuidelOrtho Corp QDEL · Entity 4986 | GrantCommon Stock | 18,762 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-22-020510 · doc4.xml · nonDerivative · entry 1 Kroll Werner · CIK 0001609320 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,762 F1 · kind: Pursuant to the Business Combination Agreement, dated as of December 22, 2021 (the "Business Combination Agreement") by and among Quidel Corporation ("Quidel"), Ortho Clinical Diagnostics Holdings plc, QuidelOrtho Corporation ("QuidelOrtho"), Orca Holdco, Inc., Laguna Merger Sub, Inc. and Orca Holdco 2, Inc., each share of common stock of Quidel beneficially owned by the Reporting Person at the effective time of the transaction contemplated by the Business Combination Agreement was exchanged for one share of common stock of QuidelOrtho. F1 · price: Pursuant to the Business Combination Agreement, dated as of December 22, 2021 (the "Business Combination Agreement") by and among Quidel Corporation ("Quidel"), Ortho Clinical Diagnostics Holdings plc, QuidelOrtho Corporation ("QuidelOrtho"), Orca Holdco, Inc., Laguna Merger Sub, Inc. and Orca Holdco 2, Inc., each share of common stock of Quidel beneficially owned by the Reporting Person at the effective time of the transaction contemplated by the Business Combination Agreement was exchanged for one share of common stock of QuidelOrtho. Read SEC document |
| February 10, 2022 Filed Feb 14, 2022 21:18 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | Exercise / conversionRestricted Stock Units (Premium) · Derivative | 210 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-009602 · doc4.xml · derivative · entry 6 Kroll Werner · CIK 0001609320 · SVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 210 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one (1) share of Quidel Corporation common stock. F4 · derivative.expiration_date: The common shares issued pursuant to the release of these restricted stock units were released pursuant to deferral periods under the Quidel Corporation Deferred Bonus Compensation Plan. Read SEC document |
| February 10, 2022 Filed Feb 14, 2022 21:18 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | Exercise / conversionRestricted Stock Units (Converted) · Derivative | 1,050 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-009602 · doc4.xml · derivative · entry 5 Kroll Werner · CIK 0001609320 · SVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,050 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one (1) share of Quidel Corporation common stock. F4 · derivative.expiration_date: The common shares issued pursuant to the release of these restricted stock units were released pursuant to deferral periods under the Quidel Corporation Deferred Bonus Compensation Plan. Read SEC document |
| February 10, 2022 Filed Feb 14, 2022 21:18 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | Tax withholdingCommon Stock | 105 | $95.34 | $10,010.70 |
DisclosureSEC source: 0001209191-22-009602 · doc4.xml · nonDerivative · entry 4 Kroll Werner · CIK 0001609320 · SVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,556 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| February 10, 2022 Filed Feb 14, 2022 21:18 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | GrantCommon Stock | 210 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-009602 · doc4.xml · nonDerivative · entry 3 Kroll Werner · CIK 0001609320 · SVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,661 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| February 10, 2022 Filed Feb 14, 2022 21:18 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | Tax withholdingCommon Stock | 496 | $95.34 | $47,288.64 |
DisclosureSEC source: 0001209191-22-009602 · doc4.xml · nonDerivative · entry 2 Kroll Werner · CIK 0001609320 · SVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,451 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| February 10, 2022 Filed Feb 14, 2022 21:18 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | GrantCommon Stock | 1,050 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-009602 · doc4.xml · nonDerivative · entry 1 Kroll Werner · CIK 0001609320 · SVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,947 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| February 04, 2022 Filed Feb 8, 2022 19:36 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | Exercise / conversionRestricted Stock Units · Derivative | 4,268 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-007862 · doc4.xml · derivative · entry 3 Kroll Werner · CIK 0001609320 · SVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,268 Underlying: Common Stock · 4,268 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one (1) share of Quidel Corporation common stock. F4 · derivative.exercise_date: One-third of the shares subject to the original grant vest annually over a three-year period, commencing on the first anniversary date of the grant date. F4 · derivative.expiration_date: One-third of the shares subject to the original grant vest annually over a three-year period, commencing on the first anniversary date of the grant date. Read SEC document |
| February 04, 2022 Filed Feb 8, 2022 19:36 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | Tax withholdingCommon Stock | 1,966 | $98.87 | $194,378.42 |
DisclosureSEC source: 0001209191-22-007862 · doc4.xml · nonDerivative · entry 2 Kroll Werner · CIK 0001609320 · SVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,897 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| February 04, 2022 Filed Feb 8, 2022 19:36 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | GrantCommon Stock | 4,268 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-007862 · doc4.xml · nonDerivative · entry 1 Kroll Werner · CIK 0001609320 · SVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,863 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| February 01, 2022 Filed Feb 2, 2022 21:57 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | Exercise / conversionRestricted Stock Units · Derivative | 1,312 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-006637 · doc4.xml · derivative · entry 5 Kroll Werner · CIK 0001609320 · SVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,625 Underlying: Common Stock · 1,312 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one (1) share of Quidel Corporation common stock. F6 · derivative.exercise_date: One-third of the shares subject to the original grant vest annually over a three-year period, commencing on the first anniversary date of the grant date. F6 · derivative.expiration_date: One-third of the shares subject to the original grant vest annually over a three-year period, commencing on the first anniversary date of the grant date. Read SEC document |
| February 01, 2022 Filed Feb 2, 2022 21:57 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | Tax withholdingCommon Stock | 651 | $102.32 | $66,610.32 |
DisclosureSEC source: 0001209191-22-006637 · doc4.xml · nonDerivative · entry 2 Kroll Werner · CIK 0001609320 · SVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,595 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| February 01, 2022 Filed Feb 2, 2022 21:57 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | GrantCommon Stock | 1,312 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-006637 · doc4.xml · nonDerivative · entry 1 Kroll Werner · CIK 0001609320 · SVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,246 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| January 31, 2022 Filed Feb 2, 2022 21:57 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | GrantRestricted Stock Units · Derivative | 7,256 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-006637 · doc4.xml · derivative · entry 4 Kroll Werner · CIK 0001609320 · SVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,256 Underlying: Common Stock · 7,256 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one (1) share of Quidel Corporation common stock. F5 · derivative.exercise_date: 3,628 shares vest on the second anniversary date of the grant date, January 31, 2024; 1,814 shares vest on the third anniversary date of the grant date, January 31, 2025; and 1,814 shares vest on the fourth anniversary date of the grant date, January 31, 2026. F5 · derivative.expiration_date: 3,628 shares vest on the second anniversary date of the grant date, January 31, 2024; 1,814 shares vest on the third anniversary date of the grant date, January 31, 2025; and 1,814 shares vest on the fourth anniversary date of the grant date, January 31, 2026. Read SEC document |
| January 31, 2022 Filed Feb 2, 2022 21:57 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | GrantRestricted Stock Units · Derivative | 10,642 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-006637 · doc4.xml · derivative · entry 3 Kroll Werner · CIK 0001609320 · SVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,642 Underlying: Common Stock · 10,642 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one (1) share of Quidel Corporation common stock. F4 · derivative.exercise_date: 3,547 shares vest on the first anniversary date of the grant date, January 31, 2023; 3,547 shares vest on the second anniversary date of the grant date, January 31, 2024; and 3,548 shares vest on the third anniversary date of the grant date, January 31, 2025. F4 · derivative.expiration_date: 3,547 shares vest on the first anniversary date of the grant date, January 31, 2023; 3,547 shares vest on the second anniversary date of the grant date, January 31, 2024; and 3,548 shares vest on the third anniversary date of the grant date, January 31, 2025. Read SEC document |
| January 16, 2022 Filed Jan 19, 2022 20:08 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | Exercise / conversionRestricted Stock Units · Derivative | 4,606 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-003880 · doc4.xml · derivative · entry 3 Kroll Werner · CIK 0001609320 · SVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,606 shares Expires 2022-01-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit represents the right to receive one (1) share of Quidel Corporation common stock. Read SEC document |
| January 16, 2022 Filed Jan 19, 2022 20:08 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | Tax withholdingCommon Stock | 2,432 | $114.88 | $279,388.16 |
DisclosureSEC source: 0001209191-22-003880 · doc4.xml · nonDerivative · entry 2 Kroll Werner · CIK 0001609320 · SVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,934 F3 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| January 16, 2022 Filed Jan 19, 2022 20:08 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | GrantCommon Stock | 4,606 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-003880 · doc4.xml · nonDerivative · entry 1 Kroll Werner · CIK 0001609320 · SVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,366 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. F2 · balance_after: The amount of securities beneficially owned following this transaction include an additional 37 shares due to the Reporting Person's purchase of shares pursuant to the Issuer's Employee Stock Purchase Plan. Read SEC document |
| July 28, 2021 Filed Jul 30, 2021 20:12 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | GrantRestricted Stock Units · Derivative | 3,510 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-048975 · doc4.xml · derivative · entry 1 Kroll Werner · CIK 0001609320 · SVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,510 Underlying: Common Stock · 3,510 shares Expires not disclosed F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: 1,170 shares vest on the first anniversary of the grant date, July 28, 2022; 1,170 shares vest on the second anniversary of the grant date, July 28, 2023; and 1,170 shares vest on the third anniversary of the grant date, July 28, 2024. F2 · derivative.expiration_date: 1,170 shares vest on the first anniversary of the grant date, July 28, 2022; 1,170 shares vest on the second anniversary of the grant date, July 28, 2023; and 1,170 shares vest on the third anniversary of the grant date, July 28, 2024. Read SEC document |
| July 01, 2021 Filed Jul 2, 2021 18:08 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | Exercise / conversionRestricted Stock Units · Derivative | 982 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-045153 · doc4.xml · derivative · entry 3 Kroll Werner · CIK 0001609320 · SVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 982 Underlying: Common Stock · 982 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F4 · derivative.exercise_date: Award of time-based restricted stock with the following vesting: 982 shares vested on the first anniversary date of the grant date, July 1, 2021; 981 shares will vest on the second anniversary date of the grant date, July 1, 2022; 981 shares will vest on the third anniversary date of the grant date, July 1, 2023. F4 · derivative.expiration_date: Award of time-based restricted stock with the following vesting: 982 shares vested on the first anniversary date of the grant date, July 1, 2021; 981 shares will vest on the second anniversary date of the grant date, July 1, 2022; 981 shares will vest on the third anniversary date of the grant date, July 1, 2023. Read SEC document |
| July 01, 2021 Filed Jul 2, 2021 18:08 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | Tax withholdingCommon Stock | 506 | $128.60 | $65,071.60 |
DisclosureSEC source: 0001209191-21-045153 · doc4.xml · nonDerivative · entry 2 Kroll Werner · CIK 0001609320 · SVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,723 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common share upon release of restricted stock units. Read SEC document |
| July 01, 2021 Filed Jul 2, 2021 18:08 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | Exercise / conversionCommon Stock | 982 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-045153 · doc4.xml · nonDerivative · entry 1 Kroll Werner · CIK 0001609320 · SVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,229 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| May 27, 2021 Filed Jun 1, 2021 19:56 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | Exercise / conversionRestricted Stock Units · Derivative | 4,376 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-036977 · doc4.xml · derivative · entry 3 Kroll Werner · CIK 0001609320 · SVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,376 Underlying: Common Stock · 4,376 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F4 · derivative.exercise_date: Award of time-based restricted stock with the following vesting: 4,377 shares vested on the fifth anniversary date of the grant date, May 27, 2019; 4,376 shares vested on the sixth anniversary date of the grant date, May 27, 2020; 4,376 shares vested on the seventh anniversary date of the grant date, May 27, 2021; 4,376 shares will vest on the eighth anniversary date of the grant date, May 27, 2022. F4 · derivative.expiration_date: Award of time-based restricted stock with the following vesting: 4,377 shares vested on the fifth anniversary date of the grant date, May 27, 2019; 4,376 shares vested on the sixth anniversary date of the grant date, May 27, 2020; 4,376 shares vested on the seventh anniversary date of the grant date, May 27, 2021; 4,376 shares will vest on the eighth anniversary date of the grant date, May 27, 2022. Read SEC document |
| May 27, 2021 Filed Jun 1, 2021 19:56 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | Tax withholdingCommon Stock | 2,248 | $121.50 | $273,132.00 |
DisclosureSEC source: 0001209191-21-036977 · doc4.xml · nonDerivative · entry 2 Kroll Werner · CIK 0001609320 · SVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,247 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common share upon release of restricted stock units. Read SEC document |
| May 27, 2021 Filed Jun 1, 2021 19:56 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | Exercise / conversionCommon Stock | 4,376 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-036977 · doc4.xml · nonDerivative · entry 1 Kroll Werner · CIK 0001609320 · SVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,495 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| February 24, 2021 Filed Feb 24, 2021 19:53 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | SaleCommon Stock | 5,283 | $173.71 | $917,733.70 |
DisclosureSEC source: 0001209191-21-014013 · doc4.xml · nonDerivative · entry 8 Kroll Werner · CIK 0001609320 · SVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,119 F3 · price: The weighted average sale price for these transactions was $173.7145 per share, with a range of $172.41 to $174.90. Upon request, the Reporting Person hereby undertakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares sold at each separate price. Read SEC document |
| February 23, 2021 Filed Feb 24, 2021 19:53 UTC | QUIDEL CORP /DE/ QDEL · Entity 126712 | SaleCommon Stock | 173 | $164.59 | $28,473.83 |
DisclosureSEC source: 0001209191-21-014013 · doc4.xml · nonDerivative · entry 7 Kroll Werner · CIK 0001609320 · SVP, R&D 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,402 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.